Q3 2025 Management View CEO Yasuo Takeuchi highlighted a 9% year-on-year consolidated revenue increase driven by strong growth in North America and emerging markets, with a 22% rise in North America ...

The use of glucagon-like peptide-1 receptor agonists is likely to increase the risks of inadequate bowel preparation for colonoscopy, according to a study published Feb. 12 in The American Journal of ...

A systematic review and meta-analysis of five studies suggested that patients on GLP-1 receptor agonists were more likely to ...